Patents Represented by Attorney Jack Spiegel
  • Patent number: 5248667
    Abstract: Peptides previously disclosed as useful for preventing HIV from binding to cell binding sites have now been shown to have thymoleptic qualities and to be useful for tretment of psoriasis in patients who lack antibodies against HIV.
    Type: Grant
    Filed: July 18, 1991
    Date of Patent: September 28, 1993
    Assignee: The United States of America as represented by the Secretary of the Department of Health & Human Services
    Inventors: Peter Bridge, Frederick K. Goodwin